Pasighat East MLA Tapi Darang raises alarms over increasing HIV/AIDS cases in East Siang, urging community awareness and action to eliminate the infection. Current statistics show a troubling rise, ...
The survey also found that flexible and virtual appointments, as well as transportation support, were helpful while on ...
With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...
ViiV Healthcare, the specialist HIV company majority owned by GSK (LSE: GSK), today announced the presentation of new ...
Medpage Today on MSN2d
People With HIV Can Safely Receive Kidneys From Donors With HIVKidney transplantation from donors with HIV appeared to be noninferior to donors without HIV in terms of safety for ...
The Indian Patent Office has rejected Viiv Healthcare's patent application for the HIV drug, dolutegravir, after nearly a ...
New data to be shared on GSK’s RSV vaccine across different age groups of patients at increased risk • Efficacy data for gepotidacin in ...
GSK & ViiV Healthcare to showcase advances across industry-leading infectious disease portfolio at IDWeek 2024: London, UK Monday, October 14, 2024, 14:00 Hrs [IST] GSK plc and Vi ...
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that ...
Zacks.com on MSN6d
Gilead's HIV Prevention Treatment Lenacapavir Shows PotentialGilead Sciences, Inc. GILD recently announced additional efficacy, safety and demographic data from its late-stage study on lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback